988 related articles for article (PubMed ID: 33065284)
1. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
3. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor-associated macrophages for cancer immunotherapy.
Shu Y; Cheng P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
[TBL] [Abstract][Full Text] [Related]
5. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
Front Immunol; 2021; 12():799428. PubMed ID: 34992609
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
10. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
Front Immunol; 2020; 11():89. PubMed ID: 32184777
[TBL] [Abstract][Full Text] [Related]
11. Molecular Repolarisation of Tumour-Associated Macrophages.
van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
13. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.
Zins K; Abraham D
Methods Mol Biol; 2020; 2115():289-325. PubMed ID: 32006408
[TBL] [Abstract][Full Text] [Related]
14. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
Shi L; Gu H
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
[TBL] [Abstract][Full Text] [Related]
15. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).
Su P; Li O; Ke K; Jiang Z; Wu J; Wang Y; Mou Y; Jin W
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38695252
[TBL] [Abstract][Full Text] [Related]
16. The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy.
Baradaran A; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Shadbad MA; Khosravi N; Derakhshani A; Alemohammad H; Afrashteh Nour M; Safarpour H; Silvestris N; Brunetti O; Baradaran B
Biomed Pharmacother; 2022 Feb; 146():112588. PubMed ID: 35062062
[TBL] [Abstract][Full Text] [Related]
17. Targeting macrophages: a novel avenue for cancer drug discovery.
Kumar S; Ramesh A; Kulkarni A
Expert Opin Drug Discov; 2020 May; 15(5):561-574. PubMed ID: 32141351
[No Abstract] [Full Text] [Related]
18. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
19. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor-associated macrophages in tumor immune evasion.
Huang R; Kang T; Chen S
J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
